Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ellen C. M. Cranenburg"'
Autor:
Elke J. Magdeleyns, Gozewijn D. Laverman, Herma H. Uiterwijk, Ellen C. M. Cranenburg, Ralf Westerhuis, G.W. Dalmeijer, Joline W.J. Beulens, Cees Vermeer, Leon J. Schurgers, Marjolein Herfs
Publikováno v:
Cranenburg, E C M, Schurgers, L J, Uiterwijk, H H, Beulens, J W J, Dalmeijer, G W, Westerhuis, R, Magdeleyns, E J, Herfs, M, Vermeer, C & Laverman, G D 2012, ' Vitamin K intake and status are low in hemodialysis patients ', Kidney International, vol. 82, no. 5, pp. 605-610 . https://doi.org/10.1038/ki.2012.191
Kidney International, 82(5), 605-610. ELSEVIER SCIENCE INC
Kidney International, 82(5), 605-610. Elsevier Science
Kidney International, 82(5), 605-610. Nature Publishing Group
Kidney International, 82(5), 605-610. ELSEVIER SCIENCE INC
Kidney International, 82(5), 605-610. Elsevier Science
Kidney International, 82(5), 605-610. Nature Publishing Group
Vitamin K is essential for the activity of γ-carboxyglutamate (Gla)-proteins including matrix Gla28 protein and osteocalcin; an inhibitor of vascular calcification and a bone matrix protein, respectively. Insufficient vitamin K intake leads to the p
Autor:
Stephan Heidenreich, Markus Ketteler, Leon J. Schurgers, Willi Jahnen-Dechent, Georg Schlieper, Cees Vermeer, Thilo Krueger, Ellen C. M. Cranenburg, Elke J. Magdeleyns, Juergen Floege, Ralf Westenfeld, Stefan Holzmann
Publikováno v:
American Journal of Kidney Diseases, 59(2), 186-195. W B Saunders Co-Elsevier Inc
Background: Vascular calcification is a predictor of cardiovascular morbidity and mortality. Hemodialysis patients experience severe vascular calcifications. Matrix Gla protein (MGP) is a central calcification inhibitor of the arterial wall; its acti
Autor:
Mary A. Whooley, Cees Vermeer, Joachim H. Ix, Benjamin D. Parker, Ellen C. M. Cranenburg, Leon J. Schurgers
Publikováno v:
Nephrology Dialysis Transplantation. 24:2095-2101
Vascular calcification is highly prevalent in persons with chronic kidney disease (CKD) and predicts cardiovascular disease (CVD) events. Matrix Gla protein (MGP) is a potent inhibitor of vascular calcification, and lower levels of its precursor-unca
Autor:
Vincent Brandenburg, Andreas H. Mahnken, Ellen C. M. Cranenburg, Cees Vermeer, Leon J. Schurgers, Markus Ketteler, Ulrich Gladziwa, Georg Mühlenbruch, Melanie Stenger
Publikováno v:
Thrombosis and Haemostasis. 101:359-366
SummaryMatrix γ-carboxyglutamate (Gla) protein (MGP) is a potent local inhibitor of cardiovascular calcification and accumulates at areas of calcification in its uncarboxylated form (ucMGP). We previously found significantly lower circulating ucMGP
Publikováno v:
Thrombosis and Haemostasis. 100:593-603
SummaryAmong the proteins involved in vascular calcium metabolism, the vitamin K-dependent matrix Gla-protein (MGP) plays a dominant role. Although on a molecular level its mechanism of action is not completely understood, it is generally accepted th
Publikováno v:
Thrombosis and Haemostasis. 98:120-125
SummaryVitamin K, discovered in the 1930s, functions as cofactor for the post-translational carboxylation of glutamate residues. Gammacarboxy glutamic acid (Gla)-residues were first identified in prothrombin and coagulation factors in the 1970s; subs
Autor:
Otto Bekers, Ralf Koos, Leon J. Schurgers, Robert Landewé, Thea Schoonbrood, Elke J. Magdeleyns, Ellen C. M. Cranenburg, Cees Vermeer, Vincent Brandenburg
Publikováno v:
Thrombosis and haemostasis, 104(4), 811-822. Schattauer GmbH
Thrombosis and Haemostasis, 104(4), 811-822. Georg Thieme Verlag
Thrombosis and Haemostasis, 104(4), 811-822. Georg Thieme Verlag
SummaryMatrix γ-carboxyglutamate (Gla) protein (MGP) is an important local inhibitor of vascular calcification, which can undergo two post-translational modifications: vitamin K-dependent γ-glutamate carboxylation and serine phosphorylation. While
Autor:
Ralf Westenfeld, Ellen C. M. Cranenburg, Thilo Krueger, Jürgen Floege, Harald P. Kühl, Ralf Koos, Cees Vermeer, Malte Kelm, Andreas H. Mahnken, Leon J. Schurgers, Sven Stanzel, Vincent Brandenburg
Publikováno v:
Thrombosis and haemostasis. 101(4)
SummaryMatrix-Gla Protein (MGP) is a vitamin K-dependent protein acting as a local inhibitor of vascular calcification. Vitamin K-antagonists (oral anticoagulant; OAC) inhibit the activation of MGP by blocking vitamin K-metabolism. The aim of this st
Autor:
Ellen C M, Cranenburg, Vincent M, Brandenburg, Cees, Vermeer, Melanie, Stenger, Georg, Mühlenbruch, Andreas H, Mahnken, Ulrich, Gladziwa, Markus, Ketteler, Leon J, Schurgers
Publikováno v:
Thrombosis and haemostasis. 101(2)
Matrix gamma-carboxyglutamate (Gla) protein (MGP) is a potent local inhibitor of cardiovascular calcification and accumulates at areas of calcification in its uncarboxylated form (ucMGP). We previously found significantly lower circulating ucMGP leve
Publikováno v:
Thrombosis and haemostasis. 100(4)
Among the proteins involved in vascular calcium metabolism, the vitamin K-dependent matrix Gla-protein (MGP) plays a dominant role. Although on a molecular level its mechanism of action is not completely understood, it is generally accepted that MGP